PT  - JOURNAL ARTICLE
AU  - Zarifyan, Alla
ED  - Williams, Bryan
ED  - Brown, Morris J.
TI  - PATHWAY-2 and -3
DP  - 2015 Nov 21
TA  - MD Conference Express
PG  - 12--13
VI  - 15
IP  - 28
4099  - http://mdc.sagepub.com/content/15/28/12.short
4100  - http://mdc.sagepub.com/content/15/28/12.full
AB  - PATHWAY-2 and PATHWAY-3 demonstrated that potassium-sparing diuretics are safe and effective for the treatment of hypertension. Spironolactone was significantly more effective in controlling resistant hypertension than doxazosin or bisoprolol, whereas the amiloride/HCTZ combination neutralized the undesirable changes in blood glucose and potassium while significantly lowering blood pressure.